See more : Northern Genesis Acquisition Corp. III (NGC-WT) Income Statement Analysis – Financial Results
Complete financial analysis of Honliv Healthcare Management Group Company Limited (9906.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Honliv Healthcare Management Group Company Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Synopsys, Inc. (SNPS) Income Statement Analysis – Financial Results
- Deep Diamond India Limited (DDIL.BO) Income Statement Analysis – Financial Results
- Kermode Resources Ltd. (KMDRF) Income Statement Analysis – Financial Results
- Here Media Inc. (HRDIL) Income Statement Analysis – Financial Results
- Activia Properties Inc. (3279.T) Income Statement Analysis – Financial Results
Honliv Healthcare Management Group Company Limited (9906.HK)
About Honliv Healthcare Management Group Company Limited
Honliv Healthcare Management Group Company Limited owns and operates a general hospital in Mainland China. The company provides medical and pharmaceutical services, and hospital management services. It also operates as the pharmaceutical wholesaler. As of December 31, 2021, the company operated and managed Henan Honliv Hospital with 1,500 beds in operation located in Henan Province. The company was founded in 2004 and is headquartered in Changyuan, China. Honliv Healthcare Management Group Company Limited is a subsidiary of Sunny Rock Capital Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 760.53M | 727.79M | 606.84M | 524.04M | 531.11M | 496.55M | 478.92M |
| Cost of Revenue | 615.68M | 589.39M | 471.53M | 386.45M | 360.95M | 336.59M | 319.29M |
| Gross Profit | 144.84M | 138.40M | 135.31M | 137.59M | 170.16M | 159.97M | 159.63M |
| Gross Profit Ratio | 19.05% | 19.02% | 22.30% | 26.26% | 32.04% | 32.22% | 33.33% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 71.95M | 73.35M | 68.55M | 71.20M | 21.29M | 6.72M | 6.69M |
| Selling & Marketing | 15.73M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 87.69M | 73.35M | 68.55M | 71.20M | 21.29M | 6.72M | 6.69M |
| Other Expenses | -288.00K | -421.00K | -556.00K | -244.00K | 52.60M | 178.00K | 157.00K |
| Operating Expenses | 87.40M | 72.92M | 67.99M | 70.96M | 73.88M | 48.92M | 45.91M |
| Cost & Expenses | 703.08M | 662.32M | 539.52M | 457.41M | 434.83M | 385.51M | 365.20M |
| Interest Income | 789.00K | 647.00K | 903.00K | 791.00K | 706.00K | 38.00K | 23.00K |
| Interest Expense | 7.65M | 9.35M | 13.94M | 20.08M | 23.25M | 13.22M | 17.94M |
| Depreciation & Amortization | 60.24M | 54.76M | 33.71M | 28.51M | 24.47M | 24.09M | 26.20M |
| EBITDA | 119.31M | 127.13M | 98.20M | 79.43M | 116.20M | 135.77M | 140.08M |
| EBITDA Ratio | 15.69% | 17.74% | 16.21% | 16.04% | 21.89% | 27.26% | 29.25% |
| Operating Income | 57.45M | 61.56M | 66.56M | 61.97M | 96.48M | 111.65M | 113.86M |
| Operating Income Ratio | 7.55% | 8.46% | 10.97% | 11.83% | 18.17% | 22.48% | 23.77% |
| Total Other Income/Expenses | -6.02M | 1.46M | -16.02M | -31.12M | -28.00M | -13.18M | -17.92M |
| Income Before Tax | 51.42M | 63.02M | 50.54M | 30.85M | 68.48M | 98.47M | 95.94M |
| Income Before Tax Ratio | 6.76% | 8.66% | 8.33% | 5.89% | 12.89% | 19.83% | 20.03% |
| Income Tax Expense | 12.72M | 13.68M | 13.52M | 8.66M | 18.62M | 25.01M | 24.22M |
| Net Income | 38.31M | 48.95M | 36.62M | 21.84M | 49.36M | 72.73M | 71.00M |
| Net Income Ratio | 5.04% | 6.73% | 6.03% | 4.17% | 9.29% | 14.65% | 14.83% |
| EPS | 0.07 | 0.08 | 0.06 | 0.04 | 0.08 | 0.12 | 0.12 |
| EPS Diluted | 0.07 | 0.08 | 0.06 | 0.04 | 0.08 | 0.12 | 0.12 |
| Weighted Avg Shares Out | 584.32M | 592.06M | 600.00M | 520.49M | 600.00M | 600.00M | 600.00M |
| Weighted Avg Shares Out (Dil) | 584.32M | 592.06M | 600.00M | 520.49M | 600.00M | 600.00M | 600.00M |
Source: https://incomestatements.info
Category: Stock Reports